420 with CNW — Gallup Poll Finds Americans Think Cannabis Better than Alcohol for Society

Consecutive surveys over the past couple of years have revealed that attitudes toward cannabis have been steadily shifting toward the positive. After decades of criminalization, over policing, harsh sentencing and anti-cannabis propaganda, a large swathe of the population believed cannabis was just as dangerous as hard-core drugs such as cocaine and heroin.

But as cannabis reform has swept over the country for the past two decades, consumers have been increasingly inclined to shed their preconceived notions about cannabis. This is largely due to the fact that studies have shown that the controversial plant has a wide range of medical applications.

A new poll by Gallup, which has conducted several cannabis-related surveys in the past, shows that Americans believe that marijuana is much better for people and society compared to alcohol. The survey found that the number of Americans who believe cannabis has a positive impact on users and the community at large is more than double the number of Americans who have the same opinion about alcohol. Furthermore, the poll revealed that cannabis users were much more likely to extoll its pros compared to a small portion of alcohol drinkers who believed alcohol had a positive impact.

A reported 53% of the Americans surveyed said that cannabis had a “positive impact” on users compared to 45% who said it had a negative impact. Regarding the plant’s impact on society, 49% said that cannabis had a good impact while 50% said its impact on society has been negative. On the other hand, 27% of the people who were polled said alcohol was good for the drinker, and 23% stated that alcohol had a positive societal impact.

A majority — 75% — believed that alcohol has a net negative impact on society, and 71% said that it isn’t good for individual drinkers either. This is despite the fact that the manufacture and sale of alcohol is legal at the federal level while cannabis is still outlawed.

Some 70% of people who had used cannabis in the past were far more likely to say that it had a positive impact, and 66% believed it had a positive societal impact compared to 32% and 27% of drinkers who felt alcohol had a positive impact on consumers and society respectively.

An estimated 37% of non-cannabis users said cannabis was good for users, and 27% said it was good for society at large. In comparison, only 14% of non-alcohol-drinkers said it had a net positive impact on drinkers and society,

Overall, the Gallup poll shows that people’s perceptions of these two drugs don’t seem to be in line with federal law; the poll revealed a stark contrast between how the public sees cannabis vs. alcohol.

That shift in attitude toward marijuana is evident in the way the sales of licensed marijuana companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS) are generally on an upward trajectory despite the industry being flooded by plenty of players.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — YouGov Survey Finds 20% of Americans Have Changed Stance on Drug Policy

A new survey by YouGov has revealed that public opinion on drug policy seems to be in line with the changing legal landscape. With dozens of states now allowing recreational and medical cannabis use, a majority of Americans have access to some kind of cannabis product. The YouGov poll found that two in five Americans have changed their views on drug policy, shifting their attitudes in a more liberal direction amid sweeping cannabis reform.

The poll questioned respondents on a variety of topics, asking whether they had changed their minds on some issues, how their political views had changed, and what influenced them to consider the issue from a different angle. Overall, the respondents were polled on 11 hot-button subjects, with drug policy emerging as the second most common issue that people said they had changed their stances on.

Some 41% of respondents said that their views on drug policy had evolved, following 42% who said that their views on foreign policy had changed. An estimated 32% had changed their opinions on healthcare, 31% changed their opinions on immigration, and 28% shifted their views on gun control. The poll also asked respondents whether they had changed their views about the death penalty, same-sex marriage, racial discrimination, abortion, free speech and climate change.

Of those who shared their views on drug policy, 48% reported that they had become “more liberal,” 26% said they were “more conservative,” and 26% reported that their views had “changed in some way.” However, the YouGov survey did not cover specific drug policy issues such as cannabis legalization, expanding access to psychedelics for medical use and safe consumption sites for federally controlled drugs.

When asked what made them change their minds on drug policy, 50% said it was due to “new facts and information.” Some 47% said their opinions shifted as they matured and gained more insights about the world while 39% said world events caused them to reconsider their opinions on drug policies. An estimated 32% of the respondents changed their minds on drug policy due to conversations they had with other people, 33% due to personal experience with the issue, and 14% due to changes in their religious or moral views.

Even though the poll didn’t specifically discuss marijuana, previous surveys have found that people’s opinions on cannabis reform have shifted over the years. A 2021 poll from Gallup revealed that 68% of Americans supported recreational cannabis legalization compared to 56% in 1969. Another pair of Gallup surveys found that more Americans believe that cannabis has a positive impact on consumers and society at large compared to alcohol.

That viewpoint may cause growing numbers of consumers to switch to consuming marijuana rather than alcohol, a change that could mean entities such as Flora Growth Corp. (NASDAQ: FLGC) may have lots of opportunities to expand into different markets around the country.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Former Cannabis Regulators Want 10 Social-Equity Provisions Included in Marijuana Banking Bill

Most, if not all, state cannabis legalization bills contained social-equity provisions designed to reinvest in communities that had been disproportionately harmed by the war on drugs. These social-equity provisions would fund a variety of community-based programs to aid communities of color in a variety of facets and make it easier for people who were directly or indirectly affected by the drug war to break into the cannabis industry.

As the end of Congress approaches, policymakers, cannabis reform advocates and industry stakeholders are hoping to pass some kind of cannabis legislation before January, even if they have to compromise in some areas. One bill that could pass is cannabis banking legislation that would finally grant the state-legal industry access to banking services. Cannabis businesses are currently unable to obtain banking services due to the drug’s controlled status at the federal level, forcing those businesses to operate on a cash-only basis and limiting their access to capital and federal financial aid.

The bipartisan Secure and Fair Enforcement Banking (SAFE) Act would allow banks to service cannabis businesses without fear of federal reprisal. But before the bill is signed into law, the Cannabis Regulators of Color Coalition (CRCC) would like lawmakers to ensure it prioritizes social equity. In a paper published by The Ohio State University (OSU), Mortiz College of Law, CRCC outlines 10 social-equity provisions that would make the bill more palatable to lawmakers such as Senate Majority Chuck Schumer who prefer widespread, justice-focused reform.

The CRCC would like the banking bill to call for amendments that would make it necessary for financial institutions to prove that they are compliant with antidiscrimination laws before they can receive cannabis-related protections, for starters. The coalition says that the legislation will require “additional legislative amendments” that directly address the issues associated with equitable and fair access to critical financial services.

If not, the coalition states, small and minority-owned marijuana businesses that already have limited access to banking services and capital will continue to suffer. The CRCC’s paper comes weeks after Senate Majority Leader Chuck Schumer officially filed his long-awaited Cannabis Administration and Opportunity Act (CAOA). Although Schumer and other key players have not supported cannabis banking in the past, they have indicated that they are willing to compromise.

Schumer is currently holding talks with Senator Cory Booker and other key lawmakers regarding a possible compromise package of modest cannabis reforms that would include cannabis banking provisions.

Any reforms, such as allowing financial institutions to work with cannabis industry actors, would go a long way towards easing the environment within which companies such as Advanced Container Technologies Inc. (OTC: ACTX) operate.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — North Dakota Officials Confirm Marijuana Legalization Question Will Be on November Ballot

This coming November, voters in North Dakota will have the chance to decide on whether to legalize cannabis at the ballot. The office of the Secretary of State, Al Jaeger, approved the initiative earlier this week, certifying that all requirements to put the proposal before voters had been met.

Activists began to collect signatures for the measure, dubbed New Approach ND, in April. In total, the group collected more than 26,000 submissions, which was more than was required. The initiative’s provisions are similar to the House-approved legalization measure that was rejected by the Senate.

This measure will allow individuals aged 21 and above in the state to buy and possess up to four grams of cannabis concentrate and an ounce of marijuana. They will also be allowed to grow no more than three cannabis plants for personal use.

Upon the measure’s approval, the Health and Human Services department or any other designated agency by the measure will be in charge of licensing for marijuana businesses and developing rules for the program. Regulators will have until October 2023 to develop rules related to labeling, packaging, testing, advertising and security standards.

The measure also stipulates that no entity or individual will be permitted to own 4 retail locations or more than a single cultivation facility. This is in an effort to reduce the risk of the market being monopolized by large firms. It also highlights that the department can only license a maximum of eighteen retailers and 7 cultivation facilities.

However, the measure does not specify any child custody protections for parents who use marijuana in compliance with state law. Employers will also not be prohibited from enforcing existing drug policies that forbid the use of cannabis.

While the state’s 5% sales tax will apply to marijuana products, no additional tax will be imposed on cannabis specifically. Additionally, local jurisdictions will still be able to prohibit cannabis businesses from operating in their area, with marijuana firms being required to follow local zoning rules.

It should be noted that the public consumption of cannabis will remain prohibited once the measure is approved. Furthermore, the measure will not provide a pathway for individuals with past criminal records to expunge any convictions related to marijuana. Activists have revealed that they plan to work with legislators to enact a separate initiative that will address the expungement issue next year.

The legalization measure will be designated on the ballot as Measure 1.

Depending on what the voters decide, yet another market could give established companies such as American Cannabis Partners an extra state in which to consider expanding into in the not so distant future.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — New York to Start Receiving Social Equity Cannabis Business Applications

One thing most experts agree on is that the war on drugs was a failure, leading to the incarceration of tens of thousands of people on minor drug charges and decimating communities of color. As such, most state marijuana legalization bills contain social equity provisions that are meant to reinvest in these historically disadvantaged and overpoliced communities.

New York, which legalized recreational cannabis in early 2021, is set to start receiving applications for social equity retail licenses. State officials recently announced that the license application period will last from Aug. 25, 2022, to Sept. 26, 2022, with Albany TV station WRGB reporting that only qualified social-equity applicants will be able to tender their applications to the New York Office of Cannabis Management.

Titled Conditional Adult Use Retail Dispensary permits, these licenses will not be available to the general public. They are the latest in state efforts to ensure that the first recreational cannabis sales in New York benefit entrepreneurs who were directly affected by the decades-long war on drugs. According to WRGB, the social-equity license application program is part of the state’s Seeding Opportunity Initiative.

Candidates wishing to apply for a social-equity retail license must meet two conditions: they or a family member must have a cannabis-related arrest or conviction on their record and they should have experience running a business enterprise. Social-equity provisions are meant to reinvest in and rebuild communities that bore the brunt of the drug war and ensure communities of color benefit from recreational cannabis sales.

Cannabis has proven to be an extremely profitable product, employing hundreds of thousands of people and making the industry one of the fastest-growing sectors in the country. New York’s recreational cannabis sector is expected to be as profitable, generating billions of dollars once sales begin. Office of Cannabis Management executive director Chris Alexander says that the state is keen on removing barriers to entry that have prevented low-income communities of color that were most affected by the drug war from entering cannabis markets in other states.

New York’s recreational cannabis bill allows adults aged 21 and older to possess and consume certain amounts of cannabis. However, the 2021 Marijuana Regulation and Taxation Act doesn’t allow retail sales, and the Office of Cannabis Management has been forced to send cease and desist to more than 50 businesses that were selling cannabis illegally. Once social-equity businesses begin the first recreational sales in New York, state regulators will work on unveiling other licenses and dispensaries.

This emphasis on social equity brings to fruition one of the longstanding dreams that the marijuana industry, including actors such as Cannabis Strategic Ventures Inc. (OTC: NUGS), has had in seeking to push for reforms and end the lopsided enforcement of marijuana prohibition.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — How Brands in the Marijuana Market Can Drive Innovation

In the recent past, we have seen the rapid increase in personal wellness products and growing public health concerns create more proactive and health-conscious consumers. New market research shows that 70% of consumers purchase certain food products that have functional benefits to support their physical and mental well-being.

As more individuals begin prioritizing their health, the marijuana industry is afforded the opportunity to develop formulations that cater to these varied and evolving consumer preferences. Brands involved in the space can now create products that showcase the plant’s numerous applications by harnessing the power of minor cannabinoids and less popular terpenes instead of remaining focused on how they can continue developing more CBD and THC products.

Below are some ways players in the industry can drive innovation within the space and allow for more scientific studies on the plant’s benefits to be conducted.

Creating products to help with sleeping issues

At the moment, millennials make up the biggest share of marijuana consumers in America. This group often struggles with sleep disorders and experiences high levels of stress, which explains why they use sleep aids more than their gen X and baby boomer counterparts.

When developing new products, players in the industry may benefit from paying close attention to this type of information as well as other lifestyle habits of this group. Brands may formulate products that have been designed to optimize sleep. For instance, CBG and CBN can be paired with terpenes such as linalool and nerolidol to help consumers rest.

Creating products that allow for healthy decompressing

After a long day, many individuals like to unwind and relax. Infusion technology can be used to create cannabis drinks that are not only healthy but also afford their consumers euphoric and relaxing experiences.

Brands may use terpenes such as limonene and myrcene to create such experiences through their products, which will help drive consumption and address growing consumer demand.

Creating products that enhance an individual’s performance

Consumers in the market also seek products that enhance their physical and mental performance, which can explain the increasing demand for energy drinks. Recent research has found that minor cannabinoids such as THCv can enhance energy metabolism while terpenes such as pinene, limonene and beta-caryophyllene can improve focus. This is in addition to improving cognitive function and increasing energy.

Focusing on the creation of beverages with such compounds may benefit both companies and consumers, especially as more consumers consume less sugar-sweetened drinks.

Companies in this space, such as Prime Harvest Inc., can choose from a variety of different aspects upon which to focus their innovative efforts, and the combination of the different licensed companies working to push the envelope may result in an advanced marijuana industry in the long run.

NOTE TO INVESTORS: The latest news and updates relating to Prime Harvest Inc. are available in the company’s newsroom at https://cnw.fm/PRIME

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Stands to Gain Substantial Revenue Through Licensing of DehydraTECH(TM)

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced that Japanese Licensee, Premier Wellness Science Co. Ltd., officially launched the first generation of its new cannabidiol (“CBD”) products under the brand, “Ko.” “The exclusive rights between Premier and Lexaria are subject to two previously issued licenses for using DehydraTECH technology in Japan for non-pharmaceutical cannabinoid products… Under the terms of the license agreement with Lexaria, Premier purchased rights to the company’s DehydraTECH technology for use in the non-pharmaceutical market for CBD and hemp ingredients in oral liquid and non-liquid product form, including topical, hair care, lip care, and cosmetics,” a recent article reads. “Lexaria stands to gain substantial revenue through the licensing of DehydraTECH technology across minimum quarterly payments for use by Premier and royalties for products sold… To retain ongoing exclusivity, the minimum quarterly payments from Premier to Lexaria will begin Sept. 1, 2022, and will total US$4,527,500 during the first five years of the agreement. Additional payment beyond five years will be required to keep the license in good standing.”

To view the full article, visit https://cnw.fm/SKDNR

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 26 patents granted and roughly 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) Helps Farmers Expand into Highly Profitable Markets, Maintain Year-Round Revenue Streams

Advanced Container Technologies (OTC: ACTX) today announced that GrowPods, modular hydroponic farms that can be placed virtually anywhere, can help farmers expand into new markets and grow profitable fruits and vegetables year-round. GrowPods have the production capacity equivalent of one acre of traditional farmland in an automated, controlled, pesticide-free environment. According to Entrepreneur 360, farmers are not currently growing the most profitable crops. Adding a GrowPod or two allows farmers to add high-margin specialty crops to their revenue stream. “The GrowPod system allows farmers to move into new, highly profitable markets, and maintain revenue streams year-round,” said Douglas Heldoorn, CEO of Advanced Container Technologies. “With GrowPods, farming can be done in a controlled environment allowing farmers to eliminate pesticides and contaminants, yielding a highly desirable crop that is even better than organic.”

To view the full press release, visit https://cnw.fm/e8CcQ

About Advanced Container Technologies Inc.

Advanced Container Technologies is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer(R), that store and grind pharmaceuticals, herbs, teas and other solids or liquids. For more information, visit the company’s website at www.AdvancedContainerTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://cnw.fm/ACTX

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Sugarmade Inc. (SGMD) Subsidiary Inks MSA for Manufacturing, Distribution Expansion

Sugarmade (OTC: SGMD) subsidiary SugarRush has signed a management services agreement (“MSA”) with Canndis Inc., a California cannabis micro-license holder. The MSA outlines an expansion for the company’s manufacturing and distribution operations based on Canndis’ license, which includes delivery, manufacturing, distribution and cultivation capabilities. The MSA calls for Sugarmade to take over cannabis product manufacturing, distribution, delivery licensing and facility management ahead of Canndis’s first harvest at its Jerusalem Grade Farm; the farm is licensed for 43,560 square feet of outdoor canopy area and is growing at full capacity this season. According to the announcement, the MSA provides for the establishment of a new strategically located manufacturing and distribution hub. Sugarmade is an emerging leader in the licensed cannabis sector. “This deal will provide us with a new income stream as we apply our expertise and experience to mobilize Canndis’ assets and market positioning,” said Sugarmade CEO Jimmy Chan in the press release. “But it also has substantial strategic value because it lays a foundation for a significantly expanded manufacturing and distribution infrastructure under our control when we harvest our first crop in two months.”

To view the full press release, visit https://cnw.fm/wg9jD

About Sugarmade Inc.

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. The company’s brand portfolio includes CarryOutsupplies.com, SugarRush(TM), NUG Avenue, J Grade Farm, Lemon Glow and Budcars. For more information about the company, please visit www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SUGAR

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CWN — Four Recent Medical Marijuana Studies Worth Knowing About

A significant amount of research has been conducted in the medical marijuana field these last few years, revealing much about how the drug can be used in the management of various conditions. Below is an outline of some new studies on the use of cannabis and cannabis compounds, such as CBD, in the treatment of various conditions, including multiple sclerosis, coronavirus and fibromyalgia.

Use of CBD as potential coronavirus treatment

Figures from the World Health Organization (WHO) show that the coronavirus has caused more than 6.4 million deaths and over the last two years.

A recently conducted literature review assessed studies that tested the use of CBD to manage inflammation caused by the coronavirus. Preclinical medical marijuana studies showed promise for the compound’s impact on inflammatory outcomes of the cornea, gastrointestinal tract and lungs.

However, the authors stated in their conclusion that there wasn’t enough evidence to refute or support CBD as a repurpose medication for the treatment of inflammation and other coronavirus symptoms. They added that more clinical trials were needed to test CBD’s effectiveness.

Use of medical marijuana in managing fibromyalgia pain

Researchers from McGill University, Rutgers, Canopy Growth Corp. and the University of Montreal have assessed the potential mechanisms underlying a decrease in pain among patients with fibromyalgia who use medical marijuana.

The scientists stated that their analyses demonstrated that a decrease in levels of pain in patients could partly be explained by synchronous reductions in negative affect and sleep problems.

In their conclusion, the researchers stated that their findings showed decreases in pain, but this couldn’t be generalized to all patients with fibromyalgia who were using medical marijuana.

Impact of CBD on nerve cells in the brain

Researchers from the University of Milan collaborated with Curaleaf and Imperial College London’s Mikael Sodergren to assess CBD’s potential in treating neurodegenerative and psychiatric disorders.

The researchers focused on the brain-derived neurotrophic factor (BDNF) gene, finding that CBD could regulate the expression of this gene. Low levels of this gene, which promotes nerve cell maturation and growth, have been linked to epilepsy, Alzheimer’s, depression and schizophrenia.

Promising findings for CBD in treating multiple sclerosis

Multiple sclerosis is a chronic neurodegenerative and inflammatory illness of the central nervous system. Common symptoms of this disease include cognitive, motor, sensory and affective disturbances. New data shows that more and more patients with this illness are beginning to use cannabis-based medicinal products to manage their symptoms.

The researchers who conducted the study argue that there are promising indications for the use of cannabis-based medicinal products in the symptomatic treatment of multiple sclerosis.

It is worth noting that many people buy and use products from licensed companies such as Flora Growth Corp. (NASDAQ: FLGC) to obtain relief from a variety of disease symptoms, so it would be beneficial if researchers also studied and provided definitive guidance on the other conditions for which people say they use cannabis.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.